Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
katsumadai and A
This chart shows clinical trial protocols, not a prescription
Our Personalized Weight Loss Consultation is not just about shedding pounds
T2 (TRZ) | 60mg $179.00 Add to cart R3 (RT) | 30mg $159.00 Add to cart BPC-157 | 10mg $59.00 Add to cart GHK-Cu | 100mg $49.00 Add to cart Our standard Every products undergoes 7x testing for full-panel certification by independent, third-party analytical laboratories
Did they work for you
162,163 Retatrutide (LY-3437943), a novel triple agonist developed by Eli Lilly that targets GLP-1R, GIPR and GCGR, has shown potential in preliminary clinical data for providing excellent blood sugar control and significant weight reduction
US$ 23.85
US$ 20.73
US$ 29.47
US$ 21.67
